CMI is proud to announce that on June 6th, 2011 we obtained a new CE mark with our partner Advanced Cardiac Therapeutics’ Tempasure™ Catheter System. ACT’s Temapasure™ Catheter System is a novel irrigated electrophysiology RF ablation catheter system which implements Veritas™ Technology to allow real-time tissue temperature measurement at depth. For the first time the true tissue temperature of tissue can be measured real-time during ablation with an irrigated ablation catheter. This system is the culmination of over 2 years of development and collaboration between CMI and ACT. CMI would like to thank the ACT team for all its hard work and wish ACT great success with its amazing new product.

For more information about ACT, please visit

http://www.contract-medical.com/products/instrumented-catheters/advanced-cardiac-therapeutics/

http://www.actmed.net/